Condition
Macular Retinoschisis
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT03586193Unknown
Pars Plana Vitrectomy Alone in the Treatment of Macular Schisis in High Myopic Eyes
NCT01862627CompletedPrimary
Macular Retinoschisis and Detachment Associated With Glaucomatous Optic Neuropathy
NCT01959724Not ApplicableCompleted
Macular Detachment Associated With Intrachoroidal Cavitation
Showing all 3 trials